Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, has been added to the Record History. The previous revision, v3.5.3, has been removed from the list, reflecting an update to the page's release notes.
    Difference
    0.1%
    Check dated 2026-05-15T06:14:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    No textual changes are present in the supplied data for this page. The input contains no additions or deletions to summarize.
    Difference
    0.1%
    Check dated 2026-05-08T08:29:35.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Updates the revision/version indicator shown on the page (from “v3.5.2” to “v3.5.3”) with no visible change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:09:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:41.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page history.
    Difference
    0.1%
    Check dated 2026-03-19T05:29:11.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    New revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:29.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.